Steven Cohen's IMCR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 504,151 shares of Immunocore Holdings plc (IMCR) worth $17.5 M, representing 0.02% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in IMCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 403,304 shares. Largest reduction occurred in Q2 2022, reducing 407,058 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Immunocore Holdings plc (IMCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunocore Holdings plc (IMCR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -31,680 | Reduce 5.91% | 504,151 | $34.71 |
| Q3 2025 | -284,594 | Reduce 34.69% | 535,831 | $36.33 |
| Q2 2025 | +192,133 | Add 30.58% | 820,425 | $31.38 |
| Q1 2025 | +224,988 | Add 55.79% | 628,292 | $29.67 |
| Q4 2024 | +403,304 | New Buy | 403,304 | $29.50 |
| Q2 2022 | -407,058 | Sold Out | 0 | $0.00 |
| Q1 2022 | +394,658 | Add 3182.73% | 407,058 | $29.90 |
| Q4 2021 | -136,600 | Reduce 91.68% | 12,400 | $34.27 |
| Q3 2021 | +76,100 | Add 104.39% | 149,000 | $37.07 |
| Q2 2021 | +72,900 | New Buy | 72,900 | $39.05 |
Steven Cohen's Immunocore Holdings plc Investment FAQs
Steven Cohen first purchased Immunocore Holdings plc (IMCR) in Q2 2021, acquiring 72,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Immunocore Holdings plc (IMCR) for 10 quarters since Q2 2021.
Steven Cohen's largest addition to Immunocore Holdings plc (IMCR) was in Q4 2024, adding 403,304 shares worth $11.9 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 504,151 shares of Immunocore Holdings plc (IMCR), valued at approximately $17.5 M.
As of the Q4 2025 filing, Immunocore Holdings plc (IMCR) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Immunocore Holdings plc (IMCR) was 820,425 shares, as reported at the end of Q2 2025.